Amphastar Pharmaceuticals, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for AMPH, updated each market day.
AMPH AI Sentiment
AI sees no strong directional signal for Amphastar Pharmaceuticals, Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Sector
Exchange
Market Cap
$946,875,468
Cap Tier
Employees
1,976
Headquarters
RANCHO CUCAMONGA, CA
Listed Since
June 25, 2014
Website
AMPH Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
AMPH Volatility
Amphastar Pharmaceuticals, Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
